Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice

Surgical Neurology

Volumn 55, Issue 5, 2001, Pages 275-283

  Jensen, Randy L ^a   Wurster, Robert D ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Brain tumor; Calcium channel antagonist; Matrigel; Meningioma; Nude mouse; Xenograft

Indexed keywords

CALCIUM ANTAGONIST; DILTIAZEM; MATRIGEL; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MENINGIOMA; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; CALCIUM CHANNEL BLOCKERS; COLLAGEN; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LAMININ; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MICE; MICE, NUDE; PROTEOGLYCANS; TRANSPLANTATION, HETEROLOGOUS; VERAPAMIL;

EID: 0034983349     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(01)00444-X     Document Type: Article

References (38)

1. Meningioma; a historical study of the tumor and its surgical management
2. Commentary. Rethinking cancer
3. Intracranial meningiomas in the aged; surgical outcome in the era of computed tomography
4. 45Ca influx and cellular growth of human prostatic tumor cells
5. Inhibition of gastrin-induced proliferation of AR4-2J cells by calcium channel antagonists
6. Meningiomas
7. Use of verapamil to enhance the antiproliferative activity of BCNU in human glioma cells; an in vitro and in vivo study
8. Calcium-mediated signal transduction; biology, biochemistry, and therapy
9. Current management of meningomas
10. Verapamil concentration in cerebrospinal fluid after oral administration
11. Effect of calcium blockers on human CFU-GM with cytotoxic drugs
12. Malignant transformation of NIH-3T3 cells after subcutaneous co-injection with a reconstituted basement membrane (Matrigel)
13. Enhanced tumor growth of both primary and established human murine tumor cells in athymic mice after co-injection with Matrigel
14. Reconstituted basement membrane (Matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines
15. Clinical relevance of verapamil plasma levels in stable angina pectoris
16. Effect of verapamil on the in vitro cytotoxicity of adriamycin and vinblastine in the human tumor cells
17. MIB-1 (Ki-67) index and transforming growth factor alpha (TGFα) immunoreactivity are significant prognostic predictors for meningiomas
18. Verapamil intoxication; a literature review of overdoses and discussion of therapeutic options
19. The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582
20. Calcium channel antagonist effect on in vitro meningioma signal transduction pathways after growth factor stimulation
21. Matrigel augments xenograft transplantation of meninigmoma cells into athymic mice
22. In-vitro growth inhibition of growth factor-stimulation meningioma cells by calcium channel antagonists
23. Inhibition of in-vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists part II; additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements
24. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers
25. Angiogenesis; role of calcium-mediated signal transduction
26. Structure function analysis of signal and growth inhibition by carboxyamido-triazole. CAI
27. In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calciium, arachidonate, and inositol phosphates
28. L651582, a novel antiproliferative and antimetastatic agent
29. Inhibitory effect of calcium channel blockers on proliferation of human glioma cells in vitro
30. Implantation of human meningiomas into the subrenal capsule of the nude mouse
31. Meningiomas; a quest for optimum therapy
32. Drugs active against growth factor and oncogene phosphatidylinosital signaling pathways
33. Antiproliferative effect of verapamil alone on brain tumor cells in vitro
34. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse
35. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
36. Modulation of the response to chemotherapy in a human melanoma clone by the site of growth in the nude mouse model
37. Inhibition of tumor cell invasion by verapamil
38. +2-channel blocker co-administration; calcium kinetics in intra-glioma arteriolar smooth muscle cells